TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
151 hedge funds and large institutions have $505M invested in Tvardi Therapeutics, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 48 increasing their positions, 42 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
151
Holders Change
+7
Holders Change %
+4.86%
% of All Funds
2.98%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
27
Increased
48
Reduced
42
Closed
18
Calls
$9.22M
Puts
$10.6M
Net Calls
-$1.41M
Net Calls Change
+$1.07M
Top Buyers
Top Sellers
1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$8.04M |
2 |
First Manhattan
New York
|
-$6.83M |
3 |
Citadel Advisors
Miami,
Florida
|
-$6.1M |
4 |
![]()
Adage Capital Partners
Boston,
Massachusetts
|
-$3.22M |
5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.92M |